Insight Molecular Diagnostics Inc. Increase (Decrease) in Accounts Receivable
Insight Molecular Diagnostics Inc. (IMDX) reported Increase (Decrease) in Accounts Receivable of -$936.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $35.00K.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$971.00K, a 150.39% decline year-over-year.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $870.00K, a 38.03% decline year-over-year.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$254.00K, a 304.84% decline year-over-year.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$485.00K, a 142.96% decline from fiscal 2024.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2024 was $1.13M.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$109.00K, a 118.96% decline from fiscal 2022.
- Insight Molecular Diagnostics Inc. increase (decrease) in accounts receivable for fiscal 2022 was $575.00K, a 53.21% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$936.00K 10-Q · filed 2026-08-10 | -$66.00K derived: sum of 3 quarters · filed 2026-08-10 | -$320.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$971.00K 10-Q · filed 2026-05-13 | -$101.00K derived: sum of 2 quarters · filed 2026-05-13 | -$355.00K derived: sum of 3 quarters · filed 2026-05-13 | -$3.38M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $870.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $616.00K derived: sum of 2 quarters · filed 2026-03-26 | -$2.41M derived: sum of 3 quarters · filed 2026-08-10 | -$485.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | -$254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.28M derived: sum of 2 quarters · filed 2026-08-10 | -$1.35M 10-Q · filed 2025-11-10 | $49.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.10M 10-Q · filed 2026-08-10 | $303.00K derived: sum of 3 quarters · filed 2026-08-10 | $427.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $1.93M 10-Q · filed 2026-05-13 | $3.33M derived: sum of 2 quarters · filed 2026-05-13 | $3.46M derived: sum of 3 quarters · filed 2026-05-13 | $3.38M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.53M derived: sum of 2 quarters · filed 2026-03-26 | $1.45M derived: sum of 3 quarters · filed 2026-03-26 | $1.13M 10-K · filed 2026-03-26 |
| 2024-09-30 | $124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $48.00K derived: sum of 2 quarters · filed 2025-11-10 | -$275.00K 10-Q · filed 2025-11-10 | -$254.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$399.00K 10-Q · filed 2025-08-11 | -$378.00K derived: sum of 3 quarters · filed 2025-08-11 | -$212.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$323.00K 10-Q · filed 2025-05-12 | -$302.00K derived: sum of 2 quarters · filed 2025-05-12 | -$136.00K derived: sum of 3 quarters · filed 2025-05-12 | -$321.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $187.00K derived: sum of 2 quarters · filed 2025-03-24 | $2.00K derived: sum of 3 quarters · filed 2025-03-24 | -$109.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$19.00K derived: sum of 2 quarters · filed 2024-11-12 | -$130.00K 10-Q · filed 2024-11-12 | -$108.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$296.00K 10-Q · filed 2024-08-08 | -$274.00K derived: sum of 3 quarters · filed 2024-08-08 | -$86.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$111.00K 10-Q · filed 2024-05-15 | -$89.00K derived: sum of 2 quarters · filed 2024-05-15 | $99.00K derived: sum of 3 quarters · filed 2024-05-15 | -$221.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $210.00K derived: sum of 2 quarters · filed 2024-04-16 | -$110.00K derived: sum of 3 quarters · filed 2024-04-16 | $575.00K 10-K · filed 2024-04-16 |
| 2022-09-30 | $188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$132.00K derived: sum of 2 quarters · filed 2023-11-09 | $553.00K 10-Q · filed 2023-11-09 | $958.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $365.00K 10-Q · filed 2023-08-10 | $770.00K derived: sum of 3 quarters · filed 2023-08-10 | $777.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $685.00K 10-Q · filed 2023-05-15 | $1.09M derived: sum of 2 quarters · filed 2023-05-15 | $1.10M derived: sum of 3 quarters · filed 2023-05-15 | $1.42M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $412.00K derived: sum of 2 quarters · filed 2023-04-12 | $730.00K derived: sum of 3 quarters · filed 2023-04-12 | $1.23M 10-K · filed 2023-04-12 |
| 2021-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $325.00K derived: sum of 2 quarters · filed 2022-11-10 | $824.00K 10-Q · filed 2022-11-10 | $634.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $817.00K 10-Q · filed 2022-08-12 | $627.00K derived: sum of 3 quarters · filed 2022-08-12 | $914.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $499.00K 10-Q · filed 2022-05-12 | $309.00K derived: sum of 2 quarters · filed 2022-05-12 | $596.00K derived: sum of 3 quarters · filed 2022-05-12 | $689.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $97.00K derived: sum of 2 quarters · filed 2022-03-11 | $190.00K derived: sum of 3 quarters · filed 2022-03-11 | $182.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $380.00K derived: sum of 2 quarters · filed 2021-11-09 | $372.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $85.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$8.00K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |